Member Info for trytryandagain

Pharma and AI is certainly the hottest ticket in town from what I have read these last few months.

Would be interesting to know how many us LTH's have to reduce that free float, I for one haven't sold or traded a bean and my top up was soon as the market opened opened post RNS where I grabbed for 5.4p.

Sharebel it's probably a little early for this we got the RNS last Friday that we have moved to validation testing , before year end would be nice though.

Your post on the 5th after market closed : Well that was a monumental collapse. Looking in for no real reason. Be a lot of holds stuck here for a while.
Your post today 7th : However this company does have a number of fingers in pies for a small MC hence I’ve taken a small punt.
I say you don't know if you're coming or going, or maybe after a little reading yesterday and today you realise you want a piece on Monday as cheap as possible.

If you want to be pedantic then IQAI is the only listed business you can invest in today with market clearance.

Not correct either, the partnership have the FDA clearance.

Now that the FDA has granted market clearance, IB and AI Metrics will begin to actively market and sell LSN in the USA.

About IQ-AIIQ-AI Limited (Ticker:IQAI) is the parent company of Imaging Biometrics® focused on advanced and state of the art medical software and services. (www.iq-ai.ltd).

Does anyone here think Trevor doesn't have this partnership sewed together correctly, you don't just buy out AI Metrics it's an owned company without clause for IQAI.
Leading up to this agreement, IB assisted AI Metrics in the development of the LSN software by working closely with AI Metrics' CEO, Dr. Andrew Smith, MD, who provided valuable feedback and enhancement suggestions to IB's development team. IB also offered its regulatory expertise and is assisting AI Metrics in obtaining CE Mark and FDA 510(k) market clearance in Europe and the U.S., respectively.



"We are excited about partnering with Imaging Biometrics as we introduce LSN technology to the worldwide market," said Dr. Andrew Smith, CEO of AI Metrics. "Their development efforts have been integral to bringing LSN from promising research to commercial introduction, and the continuity of our relationship moving forward will ensure that LSN can quickly gain rapid and widespread utilization."

Hamsters 18, hopefully this answers your question some what.

https://www.thisismoney.co.uk/money/investing/article-8922133/INVESTMENT-EXTRA-Pick-mix-strategy-best-tough-times.html

Vaga exactly, Trevor will either recommend and take over or he won't... I will vote the way he suggests if it comes to T/O

The Liver Surface Nodularity (LSN) software is now available as an OsiriX MD plugin. The LSN plugin may be used with CT images from any scanner or vendor and is validated for a wide range of clinical protocols, including both non-enhanced and contrast-enhanced images.

Perhaps I have been thinking about this backwards. LSN software has been talked about and had papers written about it for years now, just like you guys and gals in your respective industries anything new that can make your job easier, quicker and cheaper you would know about through industry press, professional peers and even social media that's industry focused. This new technique will already be well researched, known about and eagerly anticipated. I was thinking how do we promote and sell this product, I am now thinking more to the lines that the queries and orders should come thick and fast themselves. This product is such a step change for the industry it's going to sell itself surely.

https://twitter.com/COST18206/status/1324464995292356608

Have a fantastic weekend all.

I think every liver specialist in the USA will know there is new tech in town and I imagine they will want it.

IG were asking me for 17.5p

Try a quote to buy 250,000 lol

Considering the amount of traders we had to clear today this has done better than I thought TBH, next week is a new week and sentiment and a good RNS can make this small float main market listed company shift at quite a pace as this week was evidence of.

If you had told me Monday 15p by end of the week I would have bitten your hand off lol. It's hard to be anything but delighted with the step change in our opportunities now, FDA was not a given and it could have easily been the other way, as it is we are now clear of the hurdle and some amazing RNS's I am sure will be on the way soon not only for LSN software but all other projects we have on the go. Exciting times and not wanting to wish my life away the next year will be very interesting now for sure.

You seem to have bought at the support level and not on yesterday spike so I would first say welcome and secondly fingers crossed this time next week you are blue and looking at a nice RNS under your belt. GL